Загрузка...

Recruitment of CD11b(+)Ly6C(+) monocytes in non-small cell lung cancer xenografts challenged by anti-VEGF antibody

A series of antibodies against vascular endothelial growth factor (VEGF) have been developed for the treatment of various types of cancer, including non-small cell lung cancer (NSCLC) in recent years. However, tumors frequently demonstrate resistance to these strategies of VEGF inhibition. Efforts t...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncol Lett
Главные авторы: Chen, Xie-Wan, Sun, Jian-Guo, Zhang, Lu-Ping, Liao, Xing-Yun, Liao, Rong-Xia
Формат: Artigo
Язык:Inglês
Опубликовано: D.A. Spandidos 2017
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494733/
https://ncbi.nlm.nih.gov/pubmed/28693213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6236
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!